Oral to IV Hydralazine Conversion
There is no established conversion ratio between oral and IV hydralazine, and these formulations should not be directly converted based on dose equivalence. Instead, IV hydralazine should be dosed according to its own dosing guidelines when parenteral therapy is required.
IV Hydralazine Dosing for Hypertensive Emergencies
When transitioning from oral to IV hydralazine in a hypertensive emergency:
- Initial IV dose: 10-20 mg via slow IV infusion 1, 2, 3, 4
- Repeat every 4-6 hours as needed 1, 2, 3
- Onset of action: 10-30 minutes, with effects lasting 2-4 hours 1, 2
The FDA label confirms the usual IV dose is 20-40 mg repeated as necessary, with certain patients (especially those with marked renal damage) requiring lower doses 4.
Critical Clinical Context
IV hydralazine is NOT a first-line agent for most hypertensive emergencies due to its unpredictable response and prolonged duration of action 1, 2, 3. The 2017 ACC/AHA guidelines explicitly state that the "unpredictability of response and prolonged duration of action do not make hydralazine a desirable first-line agent for acute treatment in most patients" 1.
When IV Hydralazine IS Appropriate:
- Severe preeclampsia/eclampsia - This is the primary indication where IV hydralazine remains clinically relevant 5, 6
- Second-line option when preferred agents (nicardipine, clevidipine, labetalol) are contraindicated or unavailable
Transition Back to Oral Therapy:
Most patients can be transferred to oral hydralazine within 24-48 hours 4. The oral dose should be based on standard oral dosing protocols (typically starting at 25-50 mg three to four times daily, maximum 300 mg/day), NOT on the IV dose administered 7, 8.
Important Safety Considerations
Avoid Common Pitfalls:
Do not use IV hydralazine for asymptomatic hypertension or hypertensive urgency - Multiple studies demonstrate increased adverse events without clear benefit 9, 10
Blood pressure monitoring is essential - Check BP frequently after administration; the maximal decrease typically occurs within 10-80 minutes 4
Risk of excessive hypotension - Particularly when combined with other antihypertensives. Profound hypotensive episodes can occur when used with diazoxide 4
Increased intracranial pressure concerns - In patients with increased intracranial pressure, lowering BP may increase cerebral ischemia 4
Tachycardia and reflex sympathetic activation - Can precipitate myocardial ischemia in susceptible patients 11
Contraindications to Consider:
- Coronary artery disease (relative contraindication due to reflex tachycardia)
- Dissecting aortic aneurysm
- Mitral valve rheumatic heart disease
The Bottom Line
Do not attempt a mathematical conversion from oral to IV hydralazine. If IV therapy is truly indicated (primarily for severe preeclampsia), start with the standard IV dose of 10-20 mg regardless of the previous oral dose. For most other hypertensive situations, consider alternative IV agents like nicardipine or labetalol that offer more predictable responses and better titratability 1, 2, 3. When transitioning back to oral therapy, use standard oral dosing protocols rather than basing the dose on IV requirements.